These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 32358544)

  • 1. SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease.
    Kim SR; Lee SG; Kim SH; Kim JH; Choi E; Cho W; Rim JH; Hwang I; Lee CJ; Lee M; Oh CM; Jeon JY; Gee HY; Kim JH; Lee BW; Kang ES; Cha BS; Lee MS; Yu JW; Cho JW; Kim JS; Lee YH
    Nat Commun; 2020 May; 11(1):2127. PubMed ID: 32358544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Empagliflozin and Liraglutide on the Nucleotide-Binding and Oligomerization Domain-Like Receptor Family Pyrin Domain-Containing 3 Inflammasome in a Rodent Model of Type 2 Diabetes Mellitus.
    Gordon M; Meagher P; Connelly KA
    Can J Diabetes; 2021 Aug; 45(6):553-556. PubMed ID: 33388277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
    Birnbaum Y; Bajaj M; Yang HC; Ye Y
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):135-145. PubMed ID: 29508169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy Inhibition Contributes to ROS-Producing NLRP3-Dependent Inflammasome Activation and Cytokine Secretion in High Glucose-Induced Macrophages.
    Dai J; Zhang X; Li L; Chen H; Chai Y
    Cell Physiol Biochem; 2017; 43(1):247-256. PubMed ID: 28854426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forskolin attenuates the NLRP3 inflammasome activation and IL-1β secretion in human macrophages.
    Chen Y; Wen JG; Feng JJ; Wang YH; Li TF; Nurmi K; Eklund KK; Xing D
    Pediatr Res; 2019 Dec; 86(6):692-698. PubMed ID: 31086288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luxeptinib disables NLRP3 inflammasome-mediated IL-1β release and pathways required for secretion of inflammatory cytokines IL-6 and TNFα.
    Sonowal H; Zhang H; Rice W; Howell SB
    Biochem Pharmacol; 2022 Jan; 195():114861. PubMed ID: 34843717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose regulates hypoxia-induced NLRP3 inflammasome activation in macrophages.
    Watanabe S; Usui-Kawanishi F; Karasawa T; Kimura H; Kamata R; Komada T; Inoue Y; Mise N; Kasahara T; Takahashi M
    J Cell Physiol; 2020 Oct; 235(10):7554-7566. PubMed ID: 32115713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRP3 Inflammasome Expression and Signaling in Human Diabetic Wounds and in High Glucose Induced Macrophages.
    Zhang X; Dai J; Li L; Chen H; Chai Y
    J Diabetes Res; 2017; 2017():5281358. PubMed ID: 28164132
    [No Abstract]   [Full Text] [Related]  

  • 9. Native low-density lipoproteins are priming signals of the NLRP3 inflammasome/interleukin-1β pathway in human adipose tissue and macrophages.
    Bissonnette S; Lamantia V; Ouimet B; Cyr Y; Devaux M; Rabasa-Lhoret R; Chrétien M; Saleh M; Faraj M
    Sci Rep; 2023 Nov; 13(1):18848. PubMed ID: 37914804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Inhibitory Capacities of 6-, 8- and 10-Gingerols/Shogaols on the Canonical NLRP3 Inflammasome-Mediated IL-1β Secretion.
    Ho SC; Chang YH
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29466287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chalcones Display Anti-NLRP3 Inflammasome Activity in Macrophages through Inhibition of Both Priming and Activation Steps-Structure-Activity-Relationship and Mechanism Studies.
    Leu WJ; Chu JC; Hsu JL; Du CM; Jiang YH; Hsu LC; Huang WJ; Guh JH
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33339319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins activate the NLRP3 inflammasome and impair insulin signaling via p38 and mTOR.
    Henriksbo BD; Tamrakar AK; Phulka JS; Barra NG; Schertzer JD
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E110-E116. PubMed ID: 32421368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE
    Leng W; Ouyang X; Lei X; Wu M; Chen L; Wu Q; Deng W; Liang Z
    Mediators Inflamm; 2016; 2016():6305735. PubMed ID: 28104929
    [No Abstract]   [Full Text] [Related]  

  • 14. SGLT-2 Inhibitors and the Inflammasome: What's Next in the 21st Century?
    Kounatidis D; Vallianou N; Evangelopoulos A; Vlahodimitris I; Grivakou E; Kotsi E; Dimitriou K; Skourtis A; Mourouzis I
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Hydroxybutyrate Deactivates Neutrophil NLRP3 Inflammasome to Relieve Gout Flares.
    Goldberg EL; Asher JL; Molony RD; Shaw AC; Zeiss CJ; Wang C; Morozova-Roche LA; Herzog RI; Iwasaki A; Dixit VD
    Cell Rep; 2017 Feb; 18(9):2077-2087. PubMed ID: 28249154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the NLRP3 inflammasome in microglia: the role of ceramide.
    Scheiblich H; Schlütter A; Golenbock DT; Latz E; Martinez-Martinez P; Heneka MT
    J Neurochem; 2017 Dec; 143(5):534-550. PubMed ID: 28940479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sendai Virus V Protein Inhibits the Secretion of Interleukin-1β by Preventing NLRP3 Inflammasome Assembly.
    Komatsu T; Tanaka Y; Kitagawa Y; Koide N; Naiki Y; Morita N; Gotoh B; Yokochi T
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinamide Riboside Ameliorates Hepatic Metaflammation by Modulating NLRP3 Inflammasome in a Rodent Model of Type 2 Diabetes.
    Lee HJ; Hong YS; Jun W; Yang SJ
    J Med Food; 2015 Nov; 18(11):1207-13. PubMed ID: 25974041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A casein hydrolysate protects mice against high fat diet induced hyperglycemia by attenuating NLRP3 inflammasome-mediated inflammation and improving insulin signaling.
    Healy NP; Kirwan AM; McArdle MA; Holohan K; Nongonierma AB; Keane D; Kelly S; Celkova L; Lyons CL; McGillicuddy FC; Finucane OM; Murray BA; Kelly PM; Brennan L; FitzGerald RJ; Roche HM
    Mol Nutr Food Res; 2016 Nov; 60(11):2421-2432. PubMed ID: 27390025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-Generation Antidiabetic Sulfonylureas Inhibit Candida albicans and Candidalysin-Mediated Activation of the NLRP3 Inflammasome.
    Lowes DJ; Hevener KE; Peters BM
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.